Medical Cannabis Prospects in Canada
Prior to the introduction of Access to Cannabis for Medical Purposes Regulations (ACMPR), Health Canada had a different set of regulation under Marijuana for Medical Purpose Regulations (MMPR). MMPR was launched in March 2014 under which medical marijuana had to be purchased directly from a licensed producer which became unaffordable for a number of patients. Following the introduction of the MMPR, a series of court decisions soon followed that made Health Canada to launch ACMPR.
The ACMPR essentially reintroduces some key aspects of the MMPR with the mandate of improving access to Medical Marijuana. In August 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) came into effect, with the intention of providing regulated access to Medical Cannabis in the various forms such as fresh or dried marijuana, oil, buds and seeds.
There are currently 8 licensed producers in British Columbia and 22 licensed producers in Ontario. The Canadian cannabis market is expected to grow quickly based on various market research and industry reports. There has been a significant increase in registered medical cannabis users, eligible license holder physicians and nurse practitioners who are eligible to prescribe Medical Cannabis.
The Professional Series of Medical Cannabis Training program is developed by an expert team to address the growing need for education in cannabis sector. The series of Medical Cannabis training focuses on various modules from how to grow Marijuana legally, how to become licensed producers (LP), various processes related to pharmaceutical product development and clinical research activities, regulatory and legal realities associated with the start-up companies and medical practitioners.
Certificate of completion for specific training will be given to trainees upon completing each workshop.